Navigation Links
BIO Ventures for Global Health Opens San Francisco Office; Hires New Senior Staff
Date:7/20/2010

Washington, July 20 /PRNewswire-USNewswire/ -- BIO Ventures for Global Health (BVGH) announced today that it is expanding to the West Coast with the opening of a new San Francisco headquarters office. The expansion provides BVGH the opportunity to work even more closely with the world class biotech and investor communities on both coasts.

"We are very excited about our expansion and new location in the Bay area, one of the premier biotech centers," says Don Joseph, JD, Chief Operating Officer of BVGH.  "By establishing a West Coast location in addition to our ongoing presence in Washington, D.C., BVGH will be better able to connect with biotech companies and investors, regardless of their location, as we seek to expand companies' involvement in addressing neglected diseases of the developing world."

BVGH also announced the appointment of two new senior staff.  Jacqueline Papkoff, PhD, was appointed Vice President of Global Health Connect.  Global Health Connect is a new network created to link biopharmaceutical companies with product development partnerships, academics, NGOs, developing country researchers, and other experts involved in product research and development for neglected diseases. Papkoff has worked for more than 20 years in the biotech and pharmaceutical industry and has extensive scientific leadership, management, and business experience, including senior positions at diaDexus, Megabios, SUGEN, and Hoechst. Before joining BVGH, she served as a biotherapeutics R&D consultant as well as Chief Scientific Officer of CFD Therapeutics, a preclinical cancer therapeutic antibody company.

Nadine Weich, PhD, was appointed Senior Director of Scientific Affairs.  Weich most recently served as Project Team Leader for Immunology at Genentech. Before joining Genentech, she was the Director of the Department of Inflammation at Millennium Pharmaceuticals. She has more than 17 years of experience in the biopharmaceutical industry, where she focused on the research and development of antibody/protein and small molecule therapeutics for tissue growth and repair, cardiovascular, inflammation (infectious and autoimmune diseases), and oncology indications. Weich heads a Scientific Affairs department that includes Elizabeth Ponder, PhD, who brings training and experience in infectious diseases and parasitology.

"It is exciting to fill out our team with highly capable individuals who have the skills and experiences to significantly advance our programs," says Melinda Moree, BVGH Chief Executive Officer. "BVGH has doubled in size over the past year and is now staffed up to a critical mass, filled with complementary experience from the biotech, pharma, and global health sectors. This powerful combination will allow BVGH to increase the depth of its work and the creativity of its proposed solutions as we continue to create incentives and solutions to engage the innovation of the biopharmaceutical industry in addressing the crucial work of global health."

About BIO Ventures for Global Health

BIO Ventures for Global Health is a non-profit organization whose mission is to save lives by accelerating the development of novel biotechnology-based drugs, vaccines, and diagnostics to address the unmet medical needs of the developing world. The organization spurs biotech industry involvement in global health product development by increasing biotech and global health partnerships, designing and advocating for compelling market-based incentives, and synthesizing and disseminating critical information and quantitative analysis. For more information, please visit www.bvgh.org.


'/>"/>
SOURCE BIO Ventures for Global Health
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. 7 Health Ventures Invests in Tulip Medical
2. Cordex Pharma Announces Strategic Master Services Equity Agreement With Cato BioVentures
3. ThermalTherapeutic Systems Completes $2.75 Million Series A Financing With Originate Ventures
4. Fulcrum Ventures Leads $1.25 Million Investment in Path-Tec, LLC
5. Phreesia to Accelerate Growth with $16 Million Investment Led by Ascension Health Ventures
6. iPierian Closes $22 Million Series B Financing Led By Google Ventures
7. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
8. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
9. Directors Forum: PEPFAR and the Global AIDS Response
10. Alfacell Corporation to Present at UBS Global Life Sciences Conference
11. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)...  In a startling report released today, National Safety Council ... a comprehensive, proven plan to eliminate prescription opioid overdoses. ... states are tackling the worst drug crisis in recorded U.S. history, ... Kentucky , New Mexico , ... the 28 failing states, three – Michigan , ...
(Date:6/23/2016)... Pa. , June 23, 2016 Bracket ... will launch its next generation clinical outcomes platform, Bracket eCOA ... Meeting held on June 26 – 30, 2016 in ... the first electronic Clinical Outcome Assessment product of its kind ... Booth #715. Bracket eCOA 6.0 is a flexible ...
(Date:6/23/2016)... PRINCETON, N.J. , June 23, 2016  Guerbet ... of Premier Inc.,s Supplier Horizon Award . ... this year, Guerbet was recognized for its support of ... value creation through clinical excellence, and commitment to lower ... delighted to receive this recognition of our outstanding customer ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
(Date:6/24/2016)... San Francisco, CA (PRWEB) , ... June 24, ... ... at CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has ... , self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, ... minimum wage raise to $12 an hour by 2020 and then adjusting it yearly to ... value of the minimum wage, assure the wage floor does not erode again, and make ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The ... published in Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative Solutions ... initiated cultivation and processing operations at its production facility, and opened its first ... is the manufacturer of a complete system of proactive air and surface purification ...
Breaking Medicine News(10 mins):